Crisis Looms This Week Due to Zuellig Struggle Committee's Resistance to Exclusive Supply

Published: 2001-07-27 06:56:00

Updated: 2001-07-27 06:56:00

The resistance of the Zuellig Struggle Committee, headed by Lee Han-woo, is expected to take a new turn starting from over-the-counter meeting at the end of this week.

The Committee will call for a change in the business policy of multinational pharmaceutical companies including Zuellig, and ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK